Phio Pharmaceuticals (PHIO) Shares Outstanding (Weighted Average) (2016 - 2021)

Historic Shares Outstanding (Weighted Average) for Phio Pharmaceuticals (PHIO) over the last 10 years, with Q3 2021 value amounting to $13.5 million.

  • Phio Pharmaceuticals' Shares Outstanding (Weighted Average) rose 13414.63% to $13.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was $13.5 million, marking a year-over-year increase of 13414.63%. This contributed to the annual value of $4.6 million for FY2020, which is 89549.84% up from last year.
  • According to the latest figures from Q3 2021, Phio Pharmaceuticals' Shares Outstanding (Weighted Average) is $13.5 million, which was up 13414.63% from $13.5 million recorded in Q2 2021.
  • In the past 5 years, Phio Pharmaceuticals' Shares Outstanding (Weighted Average) registered a high of $13.5 million during Q3 2021, and its lowest value of $128085.0 during Q4 2018.
  • Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $2.4 million (2017), whereas its average is $4.0 million.
  • Per our database at Business Quant, Phio Pharmaceuticals' Shares Outstanding (Weighted Average) tumbled by 9432.69% in 2018 and then skyrocketed by 115119.29% in 2020.
  • Phio Pharmaceuticals' Shares Outstanding (Weighted Average) (Quarter) stood at $2.3 million in 2017, then crashed by 94.33% to $128085.0 in 2018, then soared by 259.77% to $460809.0 in 2019, then skyrocketed by 895.5% to $4.6 million in 2020, then skyrocketed by 195.04% to $13.5 million in 2021.
  • Its Shares Outstanding (Weighted Average) was $13.5 million in Q3 2021, compared to $13.5 million in Q2 2021 and $10.7 million in Q1 2021.